What are the fatality rates for the various forms of anthrax?
Early treatment of cutaneous anthrax is usually curative, and early treatment of all forms is important for recovery. Patients with cutaneous anthrax have reported case fatality rates of 20% without antibiotic treatment and less than 1% with it. Although case-fatality estimates for inhalation anthrax are based on incomplete information, we know that the rate is extremely high even when appropriate antibiotics are given. Estimates of the impact of the delay in post-exposure prophylaxis or treatment on survival are not known. For gastrointestinal anthrax, the case-fatality rate is estimated to be 25%-60%, and the effect of early antibiotic treatment on that case-fatality rate is not known.
According to CDC, early treatment of cutaneous anthrax is usually curative, and early treatment of all forms is important for recovery. Patients with cutaneous anthrax have reported fatality rates of 20% without antibiotic treatment. But the fatality rates drops to less than 1% with antibiotic treatment. So, it is very important that you get prompt treatment is you suspect exposure to anthrax bacteria. We have incomplete information about the fatality rates in case of inhalational anthrax. Unfortunately, the fatality rate, in this case, is extremely high even when appropriate antibiotics are given. We also do not know the impact of the delay in post-exposure prophylaxis or treatment on survival in this type of exposure. For gastrointestinal anthrax, the fatality rate is estimated to be 25%-60%. We do not know how early antibiotic treatment affects that fatality rate.
Early treatment of cutaneous anthrax is usually curative, and early treatment of all forms is important for recovery. Patients with cutaneous anthrax have reported case fatality rates of 20% without antibiotic treatment and less than 1% with it. Although case-fatality estimates for inhalational anthrax are based on incomplete information, we know that the rate is extremely high even when appropriate antibiotics are given. Estimates of the impact of the delay in post-exposure prophylaxis or treatment on survival are not known. For gastrointestinal anthrax, the case-fatality rate is estimated to be 25%-60%, and the effect of early antibiotic treatment on that case-fatality rate is not known.
Related Questions
- When will the Department propose rules governing the manner in which forms and rates for the various classifications of risks insured under inland marine insurance are regulated?
- What are the case fatality rates for the various forms of anthrax?
- What are the fatality rates for the various forms of anthrax?
